The Mass Spectrometry society of Japan - The 68th Annual Conference on Mass Spectrometry, Japan

Abstract

Oral Sessions

Day 2, June 23(Thu.) 9:00-9:20 Room B (409 and 410)

Example of mass spectrometry-based biomarker measurement for drug development

(Astellas Pharma)
oFumio Osaki

This presentation outlines translational science in drug development and provides an example of mass spectrometry-based biomarker measurement for research and development of antibody drugs.